Gouin F, Noailles T
CHU de Nantes, Clinique Chirurgicale Orthopédique et Traumatologique, Hôtel-Dieu, place A.-Ricordeau, 44093 Nantes cedex, France; LPRO, Inserm UI957, Laboratoire de la Résorption Osseuse et des Tumeurs Osseuses Primitives, Faculté de Médecine, Université de Nantes, 44000 Nantes, France.
CHU de Nantes, Clinique Chirurgicale Orthopédique et Traumatologique, Hôtel-Dieu, place A.-Ricordeau, 44093 Nantes cedex, France.
Orthop Traumatol Surg Res. 2017 Feb;103(1S):S91-S97. doi: 10.1016/j.otsr.2016.11.002. Epub 2017 Jan 2.
Tenosynovial giant cell tumor (TSGCT) is a rare benign tumor arising from joint synovia, bursae and tendon sheaths. Their variable clinical presentation is related to variations in site and progression. Localized forms are most frequent in the hands, and diffuse forms in the knee. MRI is necessary and sometimes sufficient for diagnosis. Treatment strategy is guided by progression, symptomatology, location and diathesis. Optimally complete resection is the principle of first-line treatment. Radiation therapy is effective and targeted therapies are promising; both should especially be considered in case of relapse.
腱鞘巨细胞瘤(TSGCT)是一种罕见的良性肿瘤,起源于关节滑膜、滑囊和腱鞘。其临床表现多样,与部位和病程的变化有关。局限性形式最常见于手部,弥漫性形式多见于膝关节。磁共振成像(MRI)对于诊断是必要的,有时也是充分的。治疗策略取决于病程、症状、部位和素质。最佳的完全切除是一线治疗的原则。放射治疗有效,靶向治疗前景广阔;复发时尤其应考虑这两种治疗方法。